{"id":"placebo-insulin","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Hypoglycemia"},{"rate":"10-20%","effect":"Weight gain"},{"rate":"1-5%","effect":"Allergic reactions"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Insulin is a hormone that plays a crucial role in glucose regulation. It binds to its receptor on the surface of cells, triggering a signaling cascade that ultimately leads to the uptake of glucose from the bloodstream into cells.","oneSentence":"Insulin works by lowering blood sugar levels by stimulating glucose uptake in cells.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:27:46.401Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Type 1 diabetes"},{"name":"Type 2 diabetes"}]},"trialDetails":[{"nctId":"NCT05713799","phase":"PHASE2","title":"Trial of the Combination of Alpha-Lipoic Acid and Mirabegron in Women and in Men With Obesity","status":"NOT_YET_RECRUITING","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2026-04-01","conditions":"Insulin Resistance, Obesity","enrollment":60},{"nctId":"NCT05933499","phase":"PHASE2","title":"Effect of Tirzepatide and Bimagrumab on Body Composition, Insulin Sensitivity, and Bone in Adults With Obesity","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2025-11-05","conditions":"Obesity","enrollment":63},{"nctId":"NCT02346838","phase":"NA","title":"Prebiotics, Gut Microbiota, and Cardiometabolic Health","status":"COMPLETED","sponsor":"Virginia Polytechnic Institute and State University","startDate":"2014-01","conditions":"Prediabetes","enrollment":22},{"nctId":"NCT07037420","phase":"PHASE2","title":"ALXN2420 Versus Placebo in Combination With Somatostatin Analogs in Participants With Acromegaly","status":"RECRUITING","sponsor":"Alexion Pharmaceuticals, Inc.","startDate":"2025-10-28","conditions":"Acromegaly","enrollment":60},{"nctId":"NCT05062785","phase":"PHASE1","title":"Dose-Finding Study of Intranasal Insulin in Healthy Participants Insulin in Healthy Participants","status":"COMPLETED","sponsor":"Robert Silbergleit","startDate":"2021-10-04","conditions":"Out-Of-Hospital Cardiac Arrest, Healthy","enrollment":24},{"nctId":"NCT06274749","phase":"NA","title":"Effects of Urolithin A Supplementation on Glucose Metabolism in Healthy Adults 55 >= Years Old: A Randomized Triple-Masked Controlled Clinical Trial","status":"RECRUITING","sponsor":"National Institute on Aging (NIA)","startDate":"2026-04-01","conditions":"Healthy Volunteer","enrollment":180},{"nctId":"NCT07446998","phase":"PHASE2","title":"Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Loss","status":"RECRUITING","sponsor":"Veru Inc.","startDate":"2026-03","conditions":"Obesity & Overweight, Mobility Disability, HOMA-IR","enrollment":200},{"nctId":"NCT07284316","phase":"PHASE2, PHASE3","title":"Effect of a Multidomain Intervention Plus Turmeric on the Prevention of Cognitive Decline in People Over 55 Years of Age With Insulin Resistance.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Instituto Mexicano del Seguro Social","startDate":"2025-02-20","conditions":"Cognitive Decline, Subjective Cognitive Impairment, Insulin Resistance","enrollment":100},{"nctId":"NCT06735651","phase":"NA","title":"Wild Blueberries for Gut, Brain, and Cardiometabolic Health in Prediabetes","status":"RECRUITING","sponsor":"Georgia State University","startDate":"2024-09-20","conditions":"Prediabetes (Insulin Resistance, Impaired Glucose Tolerance), Female, Adult","enrollment":30},{"nctId":"NCT05610800","phase":"PHASE2","title":"Exenatide for Smoking Cessation and Prevention of Weight Gain","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2022-12-07","conditions":"Smoking Cessation, Weight Gain","enrollment":140},{"nctId":"NCT07384052","phase":"PHASE1","title":"Safety and Feasibility of Intranasal Insulin in Patients With Spinal Cord Injury","status":"RECRUITING","sponsor":"HealthPartners Institute","startDate":"2026-02-20","conditions":"Spinal Cord Injury","enrollment":12},{"nctId":"NCT06551285","phase":"NA","title":"Study of the Effect of a Nutritional Supplement on Microbiota, Metabolic Control, Inflammatory Profile, and Quality of Life in Patients With Polycystic Ovary Syndrome.","status":"RECRUITING","sponsor":"Celia Bañuls","startDate":"2024-02-01","conditions":"Polycystic Ovary Syndrome, Metabolic Syndrome","enrollment":120},{"nctId":"NCT07466173","phase":"NA","title":"The Importance of Insulin Action in the Brain for the Immune System During Physical Activity-Overweight","status":"NOT_YET_RECRUITING","sponsor":"University of Ulm","startDate":"2026-04","conditions":"Insulin Sensitivity","enrollment":8},{"nctId":"NCT07329088","phase":"NA","title":"Isoleucine Addition Treatment Effects in a Controlled Diet Study","status":"NOT_YET_RECRUITING","sponsor":"Jean L. Fry","startDate":"2026-05-04","conditions":"Prediabetes (Insulin Resistance, Impaired Glucose Tolerance), Metabolic Syndrome (MetS), Obesity & Overweight","enrollment":40},{"nctId":"NCT07137585","phase":"PHASE1","title":"A Study to Evaluate the Effect of RO7204239 on Insulin Sensitivity and Muscle Composition in Participants With Type 2 Diabetes Mellitus (T2DM) and Overweight or Obesity","status":"RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2025-09-30","conditions":"Type 2 Diabetes Mellitus, Obesity, Overweight","enrollment":30},{"nctId":"NCT06334133","phase":"PHASE3","title":"Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes","status":"RECRUITING","sponsor":"vTv Therapeutics","startDate":"2024-06-14","conditions":"Diabetes Mellitus, Type 1","enrollment":150},{"nctId":"NCT06982313","phase":"","title":"Long-term Follow-up of the TAM-01 Study and Pooled Analysis of Low-dose Tamoxifen Studies in Non-invasive or Microinvasive Breast Neoplasms","status":"COMPLETED","sponsor":"Ente Ospedaliero Ospedali Galliera","startDate":"1996-07-01","conditions":"Breast Cancer Invasive","enrollment":1545},{"nctId":"NCT06945406","phase":"PHASE1","title":"A Study of LY4057996 in Healthy Participants and Participants With Type 1 and Type 2 Diabetes","status":"RECRUITING","sponsor":"Eli Lilly and Company","startDate":"2025-05-16","conditions":"Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2","enrollment":124},{"nctId":"NCT07465224","phase":"PHASE2","title":"A Study to Evaluate ALN-4324 on Insulin Sensitivity in Adults With Type 2 Diabetes Mellitus","status":"RECRUITING","sponsor":"Alnylam Pharmaceuticals","startDate":"2026-01-15","conditions":"Type 2 Diabetes Mellitus (T2DM)","enrollment":40},{"nctId":"NCT04596631","phase":"PHASE3","title":"A Research Study to Compare a New Medicine Oral Semaglutide to a Dummy Medicine in Children and Teenagers With Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2020-11-02","conditions":"Diabetes Mellitus, Type 2","enrollment":132},{"nctId":"NCT00690066","phase":"PHASE2","title":"PROCHYMAL® (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)","status":"COMPLETED","sponsor":"Mesoblast, Inc.","startDate":"2008-06-11","conditions":"Type 1 Diabetes Mellitus, Type 1 Diabetes, Diabetes Mellitus, Insulin-Dependent","enrollment":63},{"nctId":"NCT05040321","phase":"PHASE1, PHASE2","title":"Sirtuin-NAD Activator in Alzheimer's Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2021-12-01","conditions":"Alzheimer's Disease (Incl Subtypes), Dementia","enrollment":22},{"nctId":"NCT07461103","phase":"PHASE2","title":"Effect of Topical Insulin on Healing Rate of Pemphigus Lesions","status":"COMPLETED","sponsor":"Alexandria University","startDate":"2024-06-22","conditions":"Pemphigus Vulgaris, Skin Erosion, Autoimmune Blistering Disease","enrollment":20},{"nctId":"NCT04722354","phase":"PHASE2","title":"Abscisic Acid Effects on Glucose Homeostasis and Insulin Sensitivity","status":"COMPLETED","sponsor":"AdventHealth Translational Research Institute","startDate":"2021-03-08","conditions":"Pre Diabetes","enrollment":5},{"nctId":"NCT04958109","phase":"PHASE1","title":"Evaluation of Kisspeptin Glucose-Stimulated Insulin Secretion With Oral Glucose Tolerance Test","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2021-10-28","conditions":"Metabolic Diseases","enrollment":16},{"nctId":"NCT07258394","phase":"PHASE3","title":"Clinical Study for Dimethyl Fumarate in Preserving Islet β-Cell Function in Type 1 Diabetes Mellitus","status":"RECRUITING","sponsor":"Nanjing Medical University","startDate":"2026-01-27","conditions":"Type 1 Diabetes","enrollment":90},{"nctId":"NCT06747468","phase":"PHASE3","title":"Avexitide for Treatment of Post-Bariatric Hypoglycemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Amylyx Pharmaceuticals Inc.","startDate":"2025-04-29","conditions":"Post Bariatric Hypoglycemia","enrollment":75},{"nctId":"NCT06982859","phase":"PHASE1","title":"A Study to Evaluate the Effect of Retatrutide on Insulin Secretion and Insulin Sensitivity in Adult Participants With Type 2 Diabetes Mellitus","status":"RECRUITING","sponsor":"Eli Lilly and Company","startDate":"2025-06-02","conditions":"Diabetes Mellitus, Insulin Sensitivity","enrollment":95},{"nctId":"NCT06076161","phase":"NA","title":"Spirulina Platensis Supplementation and Calorie Restriction in Obese Men : A Randomized Controlled Trial Protocol Study","status":"COMPLETED","sponsor":"Universitas Diponegoro","startDate":"2023-10-17","conditions":"Obesity","enrollment":35},{"nctId":"NCT06403761","phase":"PHASE1","title":"Investigating How CagriSema, Semaglutide and Cagrilintide Regulate Insulin Effects in the Body of People With Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2024-05-06","conditions":"Diabetes Mellitus, Type 2","enrollment":158},{"nctId":"NCT07440147","phase":"NA","title":"Effects of Akkermansia Muciniphila and Berberine Supplementation on Insulin Sensitivity in Night-shift Workers","status":"RECRUITING","sponsor":"FH Joanneum Gesellschaft mbH","startDate":"2026-01-20","conditions":"Obesity & Overweight, Circadian Rhythm Disorders, Gut Microbiota Modulation","enrollment":200},{"nctId":"NCT05279768","phase":"PHASE1, PHASE2","title":"Stem Cells and Secretomes for Infertility Therapy in Polycystic Ovary Syndrome (PCOS) Patients With Insulin Resistance.","status":"COMPLETED","sponsor":"PT. Prodia Stem Cell Indonesia","startDate":"2022-09-01","conditions":"Polycystic Ovary Syndrome","enrollment":44},{"nctId":"NCT07186660","phase":"PHASE2","title":"Evaluation of a Novel Insulin Sensitizer in People With Type 1 Diabetes","status":"RECRUITING","sponsor":"University of Virginia","startDate":"2026-02-22","conditions":"Type 1 Diabetes (T1D), Glycemic Control for Diabetes Mellitus, Insulin","enrollment":40},{"nctId":"NCT05018585","phase":"PHASE3","title":"A Phase III Study to Investigate if the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed With Type 1 Diabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"Diamyd Medical AB","startDate":"2022-05-19","conditions":"Type 1 Diabetes Mellitus","enrollment":330},{"nctId":"NCT06624956","phase":"PHASE4","title":"Prevention and Treatment of Common Hyperglycemia in Surgery Pilot","status":"COMPLETED","sponsor":"University of Washington","startDate":"2024-09-04","conditions":"Surgery, Non Diabetic Hyperglycemia","enrollment":106},{"nctId":"NCT07223333","phase":"PHASE1","title":"A Study of PATAS Trifluoroacetate Using Single Ascending Doses in Healthy Volunteers","status":"RECRUITING","sponsor":"AdipoPharma LLC","startDate":"2026-01-27","conditions":"Type 2 Diabetes","enrollment":56},{"nctId":"NCT07371169","phase":"NA","title":"Efficacy of Chromium Picolinate in Reducing Acanthosis Nigricans Severity in Adolescents With Insulin Resistance","status":"COMPLETED","sponsor":"Uruk University","startDate":"2025-01-01","conditions":"Insulin Resistance, Acanthosis Nigricans","enrollment":90},{"nctId":"NCT05174507","phase":"PHASE2","title":"Empagliflozin and Anakinra for the Treatment of Postprandial Hypoglycemia in Patients With Prediabetes","status":"WITHDRAWN","sponsor":"University Hospital, Basel, Switzerland","startDate":"2022-06-24","conditions":"Postprandial Hypoglycemia","enrollment":""},{"nctId":"NCT03514108","phase":"PHASE4","title":"DANHEART (H-HeFT and Met-HeFT)","status":"COMPLETED","sponsor":"Henrik Wiggers","startDate":"2018-03-01","conditions":"Heart Failure, Diabetes","enrollment":1100},{"nctId":"NCT07420998","phase":"NA","title":"Effect of a Nutritional Product Containing Carob Extract on Carbohydrate Metabolism in Glucose-intolerant Subjects","status":"RECRUITING","sponsor":"Universidad Católica San Antonio de Murcia","startDate":"2026-01-26","conditions":"Prediabetes","enrollment":30},{"nctId":"NCT07375797","phase":"NA","title":"Fecal Microbiota Transplantation Intervention on Microbiota Composition and Insulin Sensitivity in Diabetes","status":"RECRUITING","sponsor":"Central Jutland Regional Hospital","startDate":"2026-02-05","conditions":"Diabetes Mellitus Type 2, Fecal Microbiota Transplantation (FMT), Oral Glucose Tolerance Test","enrollment":16},{"nctId":"NCT06813014","phase":"PHASE4","title":"Pharmacogenetics of Response to Sitagliptin (PRS)","status":"NOT_YET_RECRUITING","sponsor":"University of Maryland, Baltimore","startDate":"2026-12","conditions":"Diabetes","enrollment":400},{"nctId":"NCT06111586","phase":"PHASE2","title":"FrexalimAB in Preservation of Endogenous insULIN Secretion Compared to Placebo in adUlts and Adolescents on Top of inSulin Therapy (FABULINUS)","status":"RECRUITING","sponsor":"Sanofi","startDate":"2023-12-11","conditions":"Type 1 Diabetes Mellitus","enrollment":192},{"nctId":"NCT07059091","phase":"PHASE2","title":"Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2026-02-12","conditions":"Chronic Obstructive Pulmonary Disease (COPD), Allergies","enrollment":334},{"nctId":"NCT06295640","phase":"NA","title":"Relative Contribution of Brain Insulin Action for Postprandial Metabolism","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Ulm","startDate":"2024-03-18","conditions":"Glucose Metabolism Disorders","enrollment":31},{"nctId":"NCT03624062","phase":"PHASE1","title":"MER3101: MAS-1 Adjuvanted Antigen-specific Immunotherapeutic for Prevention and Treatment of Type 1 Diabetes","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2020-08-31","conditions":"Type 1 Diabetes Mellitus","enrollment":21},{"nctId":"NCT06227221","phase":"PHASE2","title":"Efficacy and Safety of Sorafenib in New-Onset Type 1 Diabetes Mellitus","status":"NOT_YET_RECRUITING","sponsor":"Second Xiangya Hospital of Central South University","startDate":"2026-02","conditions":"Type 1 Diabetes","enrollment":10},{"nctId":"NCT07167693","phase":"PHASE1, PHASE2","title":"Phase 1 Trial of Arginine Hydrochloride for the Management of Diabetic Ketoacidosis in Type 2 Diabetes","status":"RECRUITING","sponsor":"David K Carroll","startDate":"2025-12-19","conditions":"Diabetes (DM), Diabetic Ketoacidosis, Ketosis Prone Diabetes","enrollment":60},{"nctId":"NCT04251585","phase":"PHASE2","title":"Intranasal Insulin in Parkinson's Disease","status":"COMPLETED","sponsor":"HealthPartners Institute","startDate":"2020-02-04","conditions":"Parkinson Disease","enrollment":31},{"nctId":"NCT07403604","phase":"PHASE1","title":"Effect of Insulin Lowering on Lipogenesis","status":"NOT_YET_RECRUITING","sponsor":"Columbia University","startDate":"2026-04","conditions":"Hyperinsulinemia, Insulin Resistance, Non-Alcoholic Fatty Liver Disease","enrollment":25},{"nctId":"NCT07398300","phase":"NA","title":"Insulin-Mediated Glucose Uptake and Organ Perfusion Assessed by Total-Body PET During GIP and GLP-1 Infusion","status":"RECRUITING","sponsor":"Rigshospitalet, Denmark","startDate":"2026-03-12","conditions":"Type 2 Diabetes, Healhty","enrollment":36},{"nctId":"NCT07389837","phase":"NA","title":"Maple Syrup Carbohydrate Dose-Response on 20-km Cycling Time-Trial Performance","status":"NOT_YET_RECRUITING","sponsor":"Université de Montréal","startDate":"2026-02-01","conditions":"Exercise, Endurance Cycling Performance, Carbohydrate Intolerance","enrollment":32},{"nctId":"NCT07383415","phase":"NA","title":"Intranasal Platelet-Rich Plasma With or Without Topical Insulin for Post-Inflammatory Anosmia","status":"NOT_YET_RECRUITING","sponsor":"Amin Javer","startDate":"2026-03-30","conditions":"Anosmia, Inflammatory Anosmia","enrollment":20},{"nctId":"NCT04666636","phase":"PHASE2","title":"Mechanisms for Activation of Beige Adipose Tissue in Humans","status":"RECRUITING","sponsor":"Philip Kern","startDate":"2020-12-07","conditions":"PreDiabetes","enrollment":65},{"nctId":"NCT07373392","phase":"NA","title":"Effects of LP-LDL® on Lipid Metabolism, Glycemic Control, Inflammatory Markers, and Cognitive Function in Individuals With Prediabetes and Diabetes Mellitus","status":"NOT_YET_RECRUITING","sponsor":"Aalborg University","startDate":"2026-01-25","conditions":"Diabete Type 1, Diabete Type 2, Prediabetes","enrollment":210},{"nctId":"NCT07376200","phase":"PHASE1","title":"Single-ascending Dose Study of HEC-151 Injection","status":"NOT_YET_RECRUITING","sponsor":"Sunshine Lake Pharma Co., Ltd.","startDate":"2026-03-11","conditions":"Healthy Adult Male","enrollment":81},{"nctId":"NCT07220694","phase":"NA","title":"Effects of Sabroxy® Supplementation on Insulin Resistance and Cognitive Function in Adults With Mild Cognitive Impairment and Insulin Resistance","status":"RECRUITING","sponsor":"SF Research Institute, Inc.","startDate":"2026-01-29","conditions":"Insulin Resistance, Mild Cognitive Impairment, Cognitive Decline","enrollment":140},{"nctId":"NCT03866408","phase":"EARLY_PHASE1","title":"Insulin Regulation of Lipolysis and Lipolysis Proteins","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2018-11-12","conditions":"Obesity","enrollment":64},{"nctId":"NCT04341571","phase":"PHASE2","title":"Effect of Probiotics Versus Metformin on Glycemic Control, Insulin Sensitivity and Insulin Secretion in Prediabetes.","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Guadalajara","startDate":"2019-10-24","conditions":"PreDiabetes, Impaired Glucose Tolerance, Hyperglycemia","enrollment":30},{"nctId":"NCT06722560","phase":"NA","title":"SHORT-term Effects of GLucagon-like Peptide One on BonE","status":"COMPLETED","sponsor":"Odense University Hospital","startDate":"2025-01-07","conditions":"To Investigate the Physiological Effect of GLP-1 on the Skeleton, Healthy Volunteer","enrollment":12},{"nctId":"NCT05670951","phase":"PHASE3","title":"Efficacy and Safety of ELGN-2112 on Intestinal Malabsorption in Preterm Infants","status":"RECRUITING","sponsor":"Elgan Pharma Ltd.","startDate":"2025-02-27","conditions":"Intestinal Malabsorption","enrollment":360},{"nctId":"NCT06320951","phase":"PHASE2","title":"VITAL-IMPACT: Improving Cardiometabolic Health in Black Individuals Through Therapeutic Augmentation of Cyclic Guanosine Mono-Phosphate Signaling Pathway","status":"NOT_YET_RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2026-12-01","conditions":"Cardiovascular Diseases, Insulin Sensitivity/Resistance, Metabolic Disease","enrollment":200},{"nctId":"NCT07359625","phase":"NA","title":"Effects of Ketone Bodies on Insulin Sensitivity","status":"RECRUITING","sponsor":"University of Aarhus","startDate":"2025-12-02","conditions":"Insulin Resistance, Obesity & Overweight, Energy Metabolism","enrollment":10},{"nctId":"NCT06280703","phase":"PHASE1","title":"A Study of LY3938577 in Healthy Participants and Participants With Type 1 Diabetes Mellitus (T1DM)","status":"RECRUITING","sponsor":"Eli Lilly and Company","startDate":"2024-05-15","conditions":"Healthy, Type 1 Diabetes Mellitus","enrollment":118},{"nctId":"NCT05949255","phase":"NA","title":"Probiotics and Insulin Resistance in Obese Asthmatics","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2024-04-01","conditions":"Asthma, Obesity, Insulin Resistance","enrollment":7},{"nctId":"NCT05305287","phase":"PHASE4","title":"Quantifying Hepatic Mitochondrial Fluxes in Humans","status":"RECRUITING","sponsor":"The University of Texas Health Science Center at San Antonio","startDate":"2022-11-01","conditions":"Non-Alcoholic Fatty Liver Disease, Type 2 Diabetes, Mitochondrial Metabolism Disorders","enrollment":60},{"nctId":"NCT02220920","phase":"PHASE4","title":"Efficacy and Safety Study of Canagliflozin (TA-7284) in Combination With Insulin in Patients With Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Tanabe Pharma Corporation","startDate":"2014-08","conditions":"Type 2 Diabetes Mellitus","enrollment":146},{"nctId":"NCT00971243","phase":"PHASE2","title":"Efficacy and Safety of MP-513 in Combination With Metformin in Patients With Type 2 Diabetes","status":"COMPLETED","sponsor":"Tanabe Pharma Corporation","startDate":"2009-08","conditions":"Type 2 Diabetes Mellitus","enrollment":448},{"nctId":"NCT05729282","phase":"PHASE1","title":"Glycemic Effect of Diazoxide in NAFLD","status":"COMPLETED","sponsor":"Columbia University","startDate":"2023-08-01","conditions":"Hyperinsulinemia, Insulin Resistance, Non-Alcoholic Fatty Liver Disease","enrollment":24},{"nctId":"NCT03864068","phase":"PHASE2","title":"Inositol Supplementation to Treat PCOS (INSUPP-PCOS)","status":"COMPLETED","sponsor":"Milton S. Hershey Medical Center","startDate":"2020-01-24","conditions":"Polycystic Ovary Syndrome, Anovulation, Hyperandrogenism","enrollment":154},{"nctId":"NCT00974090","phase":"PHASE3","title":"Efficacy and Safety Study of MP-513 in Combination With Sulfonylurea in Patients With Type 2 Diabetes","status":"COMPLETED","sponsor":"Tanabe Pharma Corporation","startDate":"2009-09","conditions":"Type 2 Diabetes Mellitus","enrollment":194},{"nctId":"NCT01026194","phase":"PHASE3","title":"Efficacy and Safety Study of MP-513 in Combination With Thiazolidinedione in Patients With Type 2 Diabetes","status":"COMPLETED","sponsor":"Tanabe Pharma Corporation","startDate":"2009-12","conditions":"Type 2 Diabetes Mellitus","enrollment":204},{"nctId":"NCT00628212","phase":"PHASE2","title":"Efficacy and Safety Study of MP-513 in Patients With Type 2 Diabetes","status":"COMPLETED","sponsor":"Tanabe Pharma Corporation","startDate":"2008-01","conditions":"Type 2 Diabetes","enrollment":324},{"nctId":"NCT07060456","phase":"PHASE3","title":"Efficacy and Safety of HRS9531 in Participants With Type 2 Diabetes Treated With Basal Insulin","status":"RECRUITING","sponsor":"Fujian Shengdi Pharmaceutical Co., Ltd.","startDate":"2025-07-25","conditions":"Type 2 Diabetes","enrollment":300},{"nctId":"NCT00998881","phase":"PHASE3","title":"Monotherapy Study of MP-513 in Patients With Type 2 Diabetes","status":"COMPLETED","sponsor":"Tanabe Pharma Corporation","startDate":"2009-09","conditions":"Type 2 Diabetes Mellitus","enrollment":203},{"nctId":"NCT02081599","phase":"PHASE4","title":"Efficacy and Safety Study of Teneligliptin (MP-513) in Combination With Insulin in Patients With Type 2 Diabetes","status":"COMPLETED","sponsor":"Tanabe Pharma Corporation","startDate":"2014-01","conditions":"Type 2 Diabetes Mellitus","enrollment":148},{"nctId":"NCT01072331","phase":"PHASE3","title":"Pharmacokinetic/Pharmacodynamic Study of MP-513 With Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Tanabe Pharma Corporation","startDate":"2010-02","conditions":"Type 2 Diabetes Mellitus","enrollment":99},{"nctId":"NCT03837626","phase":"PHASE2, PHASE3","title":"ENAC Blockade and Arterial Stiffness","status":"COMPLETED","sponsor":"University of Missouri-Columbia","startDate":"2019-07-15","conditions":"Overweight and Obesity, Insulin Resistance","enrollment":137},{"nctId":"NCT03875755","phase":"NA","title":"Myo-inositol for Reduction of Insulin Therapy in Gestational Diabetes Mellitus","status":"ACTIVE_NOT_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2020-03-04","conditions":"Gestational Diabetes Mellitus","enrollment":1080},{"nctId":"NCT07300982","phase":"PHASE1, PHASE2","title":"Studies of Insulin and Glucagon Action in the Liver","status":"NOT_YET_RECRUITING","sponsor":"Duke University","startDate":"2026-04","conditions":"Diabetes (DM)","enrollment":40},{"nctId":"NCT05742243","phase":"PHASE2","title":"Insulin and Abatacept in Recently-diagnosed Type 1 Diabetes","status":"COMPLETED","sponsor":"Melbourne Health","startDate":"2023-02-13","conditions":"Type 1 Diabetes, Diabetes Mellitus, Type 1","enrollment":68},{"nctId":"NCT06297603","phase":"PHASE3","title":"Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Eli Lilly and Company","startDate":"2024-03-15","conditions":"Type 2 Diabetes","enrollment":320},{"nctId":"NCT07298564","phase":"NA","title":"Effect of Magnesium and Levocarnitine on Metabolic and Clinical Outcomes in Women With Polycystic Ovarian Syndrome (PCOS)","status":"RECRUITING","sponsor":"Behnood Abbasi","startDate":"2026-01-30","conditions":"Polycystic Ovary Syndrome (PCOS)","enrollment":84},{"nctId":"NCT07247734","phase":"PHASE2","title":"The Effect of Colchicine, on Insulin Sensitivity in Individuals With Type 1 Diabetes and Systemic Low-grade Inflammation","status":"RECRUITING","sponsor":"Asger Lund, MD","startDate":"2025-12-01","conditions":"Type 1 Diabetes, Chronic Inflammation, Insulin Sensitivity","enrollment":26},{"nctId":"NCT06609356","phase":"EARLY_PHASE1","title":"Cardiometabolic Benefit of Reducing Iatrogenic Hyperinsulinemia Using Insulin Adjunctive Therapy in Type 1 Diabetes","status":"RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2025-07-03","conditions":"Type 1 Diabetes Mellitus, Glucokinase-Maturity Onset Diabetes of the Young (GCK-MODY), MODY2 Diabetes","enrollment":27},{"nctId":"NCT07057479","phase":"PHASE3","title":"Phase III Trial of SGLT2 Inhibitor and Thiazolidinedione Fixed-Dose Combination vs. Monotherapy in Type 2 Diabetes Patients on Metformin","status":"WITHDRAWN","sponsor":"Eurofarma Laboratorios S.A.","startDate":"2026-09","conditions":"Type 2 Diabetes Mellitus (T2DM)","enrollment":""},{"nctId":"NCT06812325","phase":"PHASE3","title":"A Safety and Tolerability Study of VRDN-003 in Participants With Thyroid Eye Disease (TED)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Viridian Therapeutics, Inc.","startDate":"2025-02-03","conditions":"Thyroid Eye Disease (TED)","enrollment":321},{"nctId":"NCT07271771","phase":"PHASE4","title":"The Effect of Denosumab on Muscle and Strength and Insulin Sensitivity","status":"RECRUITING","sponsor":"Aarhus University Hospital","startDate":"2024-05-21","conditions":"Osteoporosis","enrollment":40},{"nctId":"NCT02724566","phase":"PHASE1","title":"Effect of Apelin on Insulin Sensitivity in Type 2 Diabetic Volunteers","status":"COMPLETED","sponsor":"University Hospital, Toulouse","startDate":"2016-05","conditions":"Diabetes","enrollment":9},{"nctId":"NCT05180591","phase":"PHASE2","title":"Repeat BCG Vaccinations For The Treatment Of Pediatric Type 1 Diabetes","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2022-03-22","conditions":"Diabetes Mellitus, Type 1, Diabetes type1, Autoimmune Diabetes","enrollment":150},{"nctId":"NCT05866536","phase":"PHASE2","title":"Repeat BCG Vaccinations for the Treatment of New Onset Type 1 Diabetes in Children Age 8-<18 Years","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2023-05-04","conditions":"Diabetes Mellitus, Type 1 Diabetes, Diabetes type1","enrollment":100},{"nctId":"NCT06552130","phase":"NA","title":"The Importance of Insulin Action in the Brain for the Immune System During Physical Activity","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Ulm","startDate":"2024-12-15","conditions":"Insulin Sensitivity","enrollment":20},{"nctId":"NCT04128969","phase":"PHASE2","title":"Causal Mechanisms in Adolescent Arterial Stiffness","status":"ACTIVE_NOT_RECRUITING","sponsor":"Baylor College of Medicine","startDate":"2020-02-01","conditions":"Lipid Disorder, Dyslipidemias, Aortic Stiffness","enrollment":90},{"nctId":"NCT07271212","phase":"NA","title":"Scalp Care Efficacy Evaluation for Premium Revitalizing Elixir","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hungkuang University","startDate":"2025-11-01","conditions":"Scalp Health, Hair Condition, Hair Loss","enrollment":60},{"nctId":"NCT07271199","phase":"NA","title":"Eyelash Effect Evaluation for Premium Rejuvenation Eyelash Serum","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hungkuang University","startDate":"2025-11-01","conditions":"Skin Condition, Eyelash Growth, Eyelashes","enrollment":30},{"nctId":"NCT06354088","phase":"PHASE1","title":"Human Models of Selective Insulin Resistance: Alpelisib, Part I","status":"RECRUITING","sponsor":"Columbia University","startDate":"2024-04-24","conditions":"Insulin Resistance, Prediabetic State, Overweight and Obesity","enrollment":32},{"nctId":"NCT06789263","phase":"NA","title":"Effect of a Collagen Hydrolysate on Postprandial Blood Glucose Profile, Gastric Emptying and GLP-1 Release in Normoglycemic and Prediabetic Subjects","status":"COMPLETED","sponsor":"Rousselot BVBA","startDate":"2025-01-29","conditions":"Prediabetes, Normoglycemic","enrollment":30},{"nctId":"NCT03107884","phase":"EARLY_PHASE1","title":"Role of Metformin on Muscle Health of Older Adults","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Utah","startDate":"2019-08-01","conditions":"Muscle Atrophy, Insulin Resistance","enrollment":64},{"nctId":"NCT07263802","phase":"NA","title":"Effect of a Food Supplement on Glycemic Parameters in Patients With Impaired Glucose Metabolism","status":"NOT_YET_RECRUITING","sponsor":"Fondazione IRCCS Policlinico San Matteo di Pavia","startDate":"2025-12-01","conditions":"Impaired Fasting Glucose (IFG), Impaired Glucose Tolerance (Prediabetes)","enrollment":90},{"nctId":"NCT07160257","phase":"PHASE1","title":"A Study to Evaluate the Effect of Maridebart Cafraglutide on Insulin Sensitivity and β-cell Function in Participants With Type 2 Diabetes Mellitus","status":"RECRUITING","sponsor":"Amgen","startDate":"2025-08-05","conditions":"Type 2 Diabetes Mellitus","enrollment":70}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":32,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Placebo + insulin","genericName":"Placebo + insulin","companyName":"AstraZeneca","companyId":"astrazeneca","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Saizen, an insulin receptor agonist, has been studied in clinical trials for various conditions including fibromyalgia, type 2 diabetes, and prediabetes. The mechanism of Saizen involves activating the insulin receptor, a protein target.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}